Arqule Inc (ARQL)

1.36
NASDAQ : Health Care
Prev Close 1.36
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.20 / 2.30
Avg Volume 90.80K
Exchange NASDAQ
Shares Outstanding 71.12M
Market Cap 97.43M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ArQule Reports Third Quarter 2016 Financial Results

ArQule Reports Third Quarter 2016 Financial Results

ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the third quarter of 2016.

Advancements In ArQule's Proprietary Pipeline To Be Highlighted At The 2016 American Society Of Hematology Annual Meeting

Advancements In ArQule's Proprietary Pipeline To Be Highlighted At The 2016 American Society Of Hematology Annual Meeting

ArQule, Inc. (Nasdaq: ARQL) today announced that preclinical data will be presented on two molecules from its proprietary pipeline at the 2016 American Society of Hematology (ASH) Annual Meeting in San Diego,...

ArQule To Report Third Quarter 2016 Financial Results On November 7, 2016

ArQule To Report Third Quarter 2016 Financial Results On November 7, 2016

ArQule, Inc. (Nasdaq: ARQL) today announced it will report financial results for the third quarter 2016 before the market opens on Monday, November 7, 2016.

ArQule To Present At The Leerink Partners Rare Disease And Immuno-Oncology Roundtable On September 28, 2016

ArQule To Present At The Leerink Partners Rare Disease And Immuno-Oncology Roundtable On September 28, 2016

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr.

ArQule Announces Publication Of Manuscript Highlighting Preclinical Activity Of FGFR Inhibitor, ARQ 087, In Peer Reviewed Journal

ArQule Announces Publication Of Manuscript Highlighting Preclinical Activity Of FGFR Inhibitor, ARQ 087, In Peer Reviewed Journal

ArQule, Inc. (Nasdaq: ARQL) today announced the publication of a paper detailing the preclinical profile of ARQ 087, an orally available fibroblast growth factor receptor (FGFR) inhibitor.

ArQule Reports Second Quarter 2016 Financial Results

ArQule Reports Second Quarter 2016 Financial Results

ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the second quarter of 2016.

Insider Trading Alert - SUMR, CVO And ARQL Traded By Insiders

Insider Trading Alert - SUMR, CVO And ARQL Traded By Insiders

Stocks with insider trader activity include SUMR, CVO and ARQL

Insider Trading Alert - ARQL, MTSC And PFNX Traded By Insiders

Insider Trading Alert - ARQL, MTSC And PFNX Traded By Insiders

Stocks with insider trader activity include ARQL, MTSC and PFNX

Insider Trading Alert - SAVE, ARQL And THST Traded By Insiders

Insider Trading Alert - SAVE, ARQL And THST Traded By Insiders

Stocks with insider trader activity include SAVE, ARQL and THST

Insider Trading Alert - ORM, OLBK And ARQL Traded By Insiders

Insider Trading Alert - ORM, OLBK And ARQL Traded By Insiders

Stocks with insider trader activity include ORM, OLBK and ARQL

Insider Trading Alert - TIPT, RDNT And ARQL Traded By Insiders

Insider Trading Alert - TIPT, RDNT And ARQL Traded By Insiders

Stocks with insider trader activity include TIPT, RDNT and ARQL